Skip to content
10-Q

Quarterly Report

TECTONIC THERAPEUTIC, INC. TECX

0001193125-26-212016

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 18.87M sh
Shares Diluted Q1 2026 · Mar 31, 2026 18.77M sh
Shares Diluted Q1 2026 · Mar 31, 2025 17.16M sh
Capex Q1 2026 · Mar 31, 2026 $19K
Capex Q1 2026 · Mar 31, 2025 $27K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$18.41M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$13.08M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $236.89M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $253.8M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $306.25M
Stockholders Equity Q1 2026 · Mar 31, 2026 $230.42M
Stockholders Equity Q1 2026 · Dec 31, 2025 $251.33M
Stockholders Equity Q1 2026 · Mar 31, 2025 $301.04M
Stockholders Equity Q1 2026 · Dec 31, 2024 $140.78M
Current Liabilities Q1 2026 · Mar 31, 2026 $12.96M
Current Liabilities Q1 2026 · Dec 31, 2025 $9.67M
Total Liabilities Q1 2026 · Mar 31, 2026 $16.16M
Total Liabilities Q1 2026 · Dec 31, 2025 $9.71M
Current Assets Q1 2026 · Mar 31, 2026 $239.89M
Current Assets Q1 2026 · Dec 31, 2025 $257.36M
Total Assets Q1 2026 · Mar 31, 2026 $246.58M
Total Assets Q1 2026 · Dec 31, 2025 $261.04M
Eps Diluted Q1 2026 · Mar 31, 2026 −$1.34
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.93
Eps Basic Q1 2026 · Mar 31, 2026 −$1.34
Eps Basic Q1 2026 · Mar 31, 2025 −$0.93
Rd Expense Q1 2026 · Mar 31, 2026 $20.87M
Rd Expense Q1 2026 · Mar 31, 2025 $13.04M
Net Income Q1 2026 · Mar 31, 2026 −$25.24M
Net Income Q1 2026 · Mar 31, 2025 −$15.91M
Operating Income Q1 2026 · Mar 31, 2026 −$27.3M
Operating Income Q1 2026 · Mar 31, 2025 −$18.3M